Covid-19: Dr Reddy’s Gets DCGI Nod to Conduct Phase 3 Clinical Trials for Sputnik V Vaccine

The phase 3 study of Sputnik V will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in the country, the Hyderabad-based firm said in a regulatory filing.

Leave a Reply

Your email address will not be published. Required fields are marked *